Editorial: Cardiac reverse remodeling after novel heart failure therapies—volume II

Editorial: Cardiac reverse remodeling after novel heart failure therapies—volume II

Saved in:

Bibliographic Details
Main Authors:	Christian Basile, Elisabetta Salvioni, Stefania Paolillo, Piergiuseppe Agostoni, Massimo Mapelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	heart failure heart failure prognosis cardiac reverse remodeling heart failure therapies ejection fraction
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1528743/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictors of sustained reverse remodelling in patients with heart failure with reduced ejection fraction
by: Silas Ramos Furquim, et al.
Published: (2025-06-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?
by: Massimo Mapelli, et al.
Published: (2025-03-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Assessment of Left Ventricular Reverse Remodeling by Echocardiography After 90 Days of Sacubitril/Valsartan Therapy in Patients of Heart Failure with Reduced Ejection Fraction
by: Akshay Pawar, et al.
Published: (2024-12-01)

Furosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline
by: Massimo Mapelli, et al.
Published: (2025-08-01)

Is there the phenotype of chronic heart failure with “intermediate” left ventricular ejection fraction? Additional echocardiographic criteria for left ventricular systolic dysfunction in patients with chronic heart failure of ischemic origin with ejection fraction in the “gray area”
by: V. V. Syvolap, et al.
Published: (2021-06-01)

Clinical management of heart failure with improved ejection fraction: treatment and maintenance
by: XU Tianyun, et al.
Published: (2025-04-01)

Early catheter ablation: A promising and effective approach for atrial fibrillation and post-heart failure recovery—Timing matters
by: Satoshi Yanagisawa, et al.
Published: (2025-02-01)

V<sub>o2peak</sub>, Ve/V<sub>CO2</sub>, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients
by: Antonio Pagliaro, et al.
Published: (2025-05-01)

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis
by: Mileydis Alonso, et al.
Published: (2024-12-01)

Gender‐specific risks for incident cancer in patients with different heart failure phenotypes
by: Qin‐Fen Chen, et al.
Published: (2025-02-01)

Cardiac remodeling in patients with heart failure with mildly reduced ejection fraction and metabolic disorders: association with biomarkers and autonomic nervous system parameters
by: E. A. Lyasnikova, et al.
Published: (2024-05-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Ventilatory efficiency in cardiac amyloidosis—A systematic review and meta‐analysis
by: Robin Willixhofer, et al.
Published: (2025-05-01)

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love—and Maybe, Redemption
by: Milton Packer
Published: (2024-04-01)

Effects of chronic airway obstruction and atrial fibrillation on the cardiac structure and function in patients with heart failure
by: A. I. Chesnikova, et al.
Published: (2020-03-01)

Cardiac contractility modulation to enhance optimized medical therapy and improve cardiac remodeling in advanced heart failure: a case report
by: Lina Feng, et al.
Published: (2025-06-01)

Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance
by: Anthony V. Pensa, et al.
Published: (2024-08-01)

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry
by: Laura Landucci, et al.
Published: (2025-03-01)

Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study
by: Wenxian Wang, et al.
Published: (2024-12-01)

Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure
by: Sakura Nagumo, et al.
Published: (2024-12-01)

The role of impaired iron transport on exercise performance and prognosis in patients with chronic heart failure
by: Jeness Campodonico, et al.
Published: (2025-08-01)

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study
by: J. Anusha, et al.
Published: (2025-07-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Impact of Obstructive Sleep Apnea in Patients with Acute Heart Failure: A Nationwide Cohort Study
by: Abdulmajeed Alharbi, et al.
Published: (2024-11-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia
by: Omar Ahmad, et al.
Published: (2024-12-01)

Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation
by: A. A. Safiullina, et al.
Published: (2022-02-01)

Running on empty: Factors underpinning impaired cardiac output reserve in heart failure with preserved ejection fraction
by: Paula Sagmeister, et al.
Published: (2025-05-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta‐analysis
by: Patrick Savage, et al.
Published: (2024-12-01)

The Physical Activity in the Management of Heart Failure with Reduced Ejection Fraction A Review of Current Evidence and Recommendations
by: Natalia Smyl, et al.
Published: (2025-07-01)

The Impact of Continuous Cardiac Rehabilitation on the Psychological and Physiological Prognosis of Patients with Heart Failure&mdash;A Retrospective Study
by: Yan LH, et al.
Published: (2025-08-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion
by: Magdy Abdelhamid, et al.
Published: (2025-03-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

Heart Failure Etiology in Patients Undergoing Cardiac Resynchronization Therapy: Is It Relevant?
by: Silvia DEACONU, et al.
Published: (2021-06-01)

Features of cardiac remodeling and GDF 15 and NTproBNP levels in patients with heart failure and preserved ejection fraction depending on the history of myocardial infarction
by: Ya. V. Zemlianyi, et al.
Published: (2024-10-01)